Prevalence and spectrum of congenital heart disease in individuals with distal chromosome 22q11.22-23 deletions
Authors:
- Tanner J. NelsonTNTanner J. Nelson
- Daniel E. McGinnDMDaniel E. McGinn
- T. Blaine CrowleyTCT. Blaine Crowley
- Lydia RockartLRLydia Rockart
- Audrey GreenAGAudrey Green
- Victoria GiuntaVGVictoria Giunta
- Oanh TranOTOanh Tran
- Jeroen BreckpotJBJeroen Breckpot
- Ann SwillenASAnn Swillen
- Maria Cristina DigilioMDMaria Cristina Digilio
- Marta UnoltMUMarta Unolt
Preprint
Abstract
This study is aimed to determine the spectrum of congenital heart disease associated with distal 22q11.22-23 deletions flanked by low copy repeats, LCR22 D-H. We analyzed cardiology findings in 128 unrelated individuals with distal LCR22 D-H deletions. A total of 62 were newly described and 66 were derived from previous reports. We found that deletions which included LCR22-D as the proximal endpoint were the most prevalent in the cohort (104/128, 81.3%). Clinically relevant congenital heart disease was identified in 48 individuals (37.5%, 95% CI 29-46%), which is lower than the prevalence reported for typical, proximal LCR22 A-D deletions (p=3.7E-4), especially for conotruncal defects (13/128, 10.2%; p=7.1E-13). Mild to moderate CHD predominated, including ventricular septal defects (22/128), bicuspid aortic valve (9/128) and mild cardiomyopathy (3/128). Persistent truncus arteriosus was the most prevalent (n=8/13) conotruncal heart defect, but other anomalies also occurred in singleton cases. These findings support the need for cardiac evaluation in all individuals with distal 22q11.22-23 deletions, increased use of clinical genetic testing in syndromic individuals with these findings, and molecular studies in model systems. The results demostrate that reduced gene dosage of distal 22q11.21-23, particularly within the D-E region including MAPK1 and HIC2 convey risk for CHD.Keywords
This publication has 43 references indexed in Scilit:
- HIC2, a new transcription activator of SIRT1FEBS Letters, 2019
- What is new with 22q? An update from the 22q and You Center at the Children's Hospital of PhiladelphiaAmerican Journal of Medical Genetics Part A, 2018
- Delineation of a recognizable phenotype for the recurrent LCR22‐C to D/E atypical 22q11.2 deletionAmerican Journal of Medical Genetics Part A, 2016
- Birth prevalence of congenital heart defects in Norway 1994-2009—A nationwide studyAmerican Heart Journal, 2014
- Central 22q11.2 deletionsAmerican Journal of Medical Genetics Part A, 2014
- Heart defects and other features of the 22q11 distal deletion syndromeEuropean Journal of Medical Genetics, 2013
- Congenital heart defects in a novel recurrent 22q11.2 deletion harboring the genes CRKL and MAPK1American Journal of Medical Genetics Part A, 2012
- Phenotypic variability of distal 22q11.2 copy number abnormalitiesAmerican Journal of Medical Genetics Part A, 2011
- 22q11.2 Distal Deletion: A Recurrent Genomic Disorder Distinct from DiGeorge Syndrome and Velocardiofacial SyndromeThe American Journal of Human Genetics, 2008
- Tetralogy of fallot with pulmonary atresia associated with chromosome 22q11 deletionJACC, 1996